Who invested in Evozyne?
Evozyne's investors include OrbiMed, Fidelity, Valor Equity Partners and nVentures.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$81Mraised across 1 round since 2023, from 1 source
Source recordedSEC filing: $81M sold, first sale Sept 2023
From the SEC filings it signed: 9 on the team.
On the board, as filediAntonio S. GraciasMatthew M. Rizzo
Evozyne's investors include OrbiMed, Fidelity, Valor Equity Partners and nVentures.
Evozyne has raised $81M across 1 round since 2023.
Evozyne's most recent round was a Series B of $81M in Sept 2023.
Its most recent round, $81M in Sept 2023, is also its largest on record.
Evozyne's first round on record, in Sept 2023, was backed by OrbiMed, Fidelity and Valor Equity Partners and 1 others.
Evozyne's latest named round is a Series B, in Sept 2023.
Evozyne is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.